Upcoming Conferences  

Industry News

Grants to private companies          to curing neglected diseases

The Government of India                 may give non-repayable               grant-in-aid to the Pharmaceutical companies for developing drugs     for neglected tropical diseases              like Malaria, Tuberculosis...

Rational prescribing will save     billions of rupees

Pharmaceutical companies         spend billions of dollars annually       to ensure that physicians           prescribe the most expensive,    most promoted drug to the patients.

Finance Minister asks           Pharmaceutical Companies to         hold drug prices or lower them

Finance Minister urged the            drug manufacturers to put hold        on price of the drugs and have     advised the companies to expand   production so that economy of         scale can be reached to gain         can be made in terms of volume.

Pharma Industry to drive next        IT outsourcing wave

The Pharmaceutical industry               is expected to be a significant  contributor to the third wave           of outsourcing, with the US               market- worth over $4trn.     Pharmaceutical Research,           including Clinical Trials will        lead the Globalization of Healthcare processes.

Indian Pharmaceutical Industry       poised to take off

The Economic Times Bio-           Pharma Development Summit             in Mumbai, brought together the  top players of the sector and the          policy makers on a common          platform to look at the current            and future industry scenario.

Gene Therapy Drug Shows              Promise in MS Patients

Palo Alto, Calif.-based                   Bayhill Therapeutics reported           positive results from a phase....

Drug Regulators to Monitor                Side Effects

The Central Drugs Standard     Control Organization is now      planning to appoint a team of     ;    about 100 clinical....

Call for a Change

Ayurveda is one of the world's       oldest medical sciences.         However, even after five        thousand years .........

Making Drugs Safer

India has become a major hub          for clinical trials. However,          whether patients in India .....
India Developing Regulatory           Guidelines for Nanotechnology          Drugs
NIPER, the Indian National            Institute of Pharmaceutical           Education and Research, is        planning ....

Data Exclusivity: Access to        Medicine in Danger

Pharmaceuticals and                 agrochemicals are two key           sectors having direct implication      to the everyday life....

India: Ministries Say Yes To          Data Protection

Pursuant to the suggestions              made by the inter-ministerial               committee on data protection       headed by ......


 

Neeman Medical International – A leading Contract Research Organization (CRO) based out of India provides full range of clinical research services to global pharmaceutical, biotech and devices companies.

  • Based out of 5 regional offices, Neeman Medical International has access to hospitals and health care facilities across India.

  • Operational since 2001, Neeman Medical International has been awarded 106 trials for global sponsors across wide range of therapeutic areas.

  • Neeman Medical International has been awarded ISO 9001:2000 certification by United Kingdom Accreditation Service (UKAS) for Site Management, Monitoring and Data Management.

  • We are presently active in 98 sites in 22 cities with access to 600 ICH-GCP trained Investigators.

  • Record of maintaining a patient retention rate between 98.1 to 98.4% across different therapeutic areas.

  • Successfully completed 4 US FDA GCP Audits for highest enrollment globally.

 
  Subscribe Neeman Newsletter

Neeman News

Dr. Ajoy Kumar, CEO,         Neeman Medical International,           Presented a case study at the   Molecular Medicine Tri       Conference Session on Clinical    Trials Asia

Completely web based         environment in Neeman          Medical International

With the implementation of               SAS PheedIT solution,             Neeman Medical has                     established a complete web-          based environment in clinical          space. This is done with the              aim of meeting........

Clinical Trials Become Tech-       Savvy: Dr. Ajoy Kumar, CEO,     NMI

Neeman Medical International awarded ISO 9001:2000 for      Clinical Research Services

Max India Raises Fresh Capital

Max India today announced             that it has raised Rs. 1,000          crore through  a QIP

Neeman and Synergy ResearchGroup, Russia         Announces Network Alliance        for Expansion of Global Clinical         Trials Services

Neeman Medical International          (NMI) announced the          establishment of a new CRO       Worldwide Network alliance         with Synergy Research Group          (SynRG), a Russia-based CRO.
Clinical trial on Breast Cancer
Neeman Medical International           is part of a global study               enrolling patients with                 Advanced or Metastatic Breast           Cancer with ErbB2 Fluorescence ....

Clinical trial on Head and Neck Cancer

Neeman Medical International           is part of the global study           enrolling patients with locally         advanced squamous cell         carcinoma of the head and neck.
Clinical Trial on Congenital          Heart Disease
Neeman medical International is presently enrolling neonates or          infants with cyanotic congenital           heart disease palliated with ....
Clinical Trial in Lower Limb              Ischemia
Neeman Medical International           has initiated a clinical trial for             a US based device company              to determine the efficacy of the        device ....
Clinical Trial in Hepatitis B
Neeman Medical International            is currently recruiting patients          for a global trial in Hepatitis B.
Clinical study on Decompensated Heart failure
Neeman medical international is currently initiating a study for a       global trial in patients with          decompensated heart failure.
Clinical Trial in Bipolar Disorder
Neeman Medical International        is currently initiating a global trial        in subjects with bipolar disorder.         It’s a phase III study and .........

 

 www.maxindia.com

 
  Our Global Partners:  Sintesi Research  |  CTI  

     © Copyright 2006 Neeman Medical International. All Rights Reserved. Disclaimer | Privacy Policy